0
3

MORE Savings Act

7/2/2025, 1:23 AM

Summary of Bill S 2072

The bill, introduced in the 119th Congress, aims to enhance affordable access to evidence-based opioid treatments within the Medicare program. It proposes mandatory coverage of medication-assisted treatment for opioid use disorders, opioid overdose reversal medications, and recovery support services by health plans, eliminating cost-sharing requirements for these services.

Congressional Summary of S 2072

Maximizing Opioid Recovery Emergency Savings Act or the MORE Savings Act

This bill modifies coverage of opioid treatments and recovery support services under Medicare, Medicaid, and private health insurance.

Specifically, the bill requires the Center for Medicare and Medicaid Innovation to test a model in which specified opioid treatments and recovery support services are provided under Medicare without cost-sharing (e.g., coinsurance, copayments, and deductibles).

The bill also allows state Medicaid programs to cover recovery support services as part of medication-assisted treatment (MAT) and increases the applicable Federal Medical Assistance Percentage for MAT.

Additionally, beginning in 2027, private health insurers must cover specified opioid treatments and MAT-associated recovery support services without cost-sharing.

Current Status of Bill S 2072

Bill S 2072 is currently in the status of Bill Introduced since June 12, 2025. Bill S 2072 was introduced during Congress 119 and was introduced to the Senate on June 12, 2025.  Bill S 2072's most recent activity was Read twice and referred to the Committee on Finance. as of June 12, 2025

Bipartisan Support of Bill S 2072

Total Number of Sponsors
2
Democrat Sponsors
2
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
5
Democrat Cosponsors
5
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 2072

Primary Policy Focus

Alternate Title(s) of Bill S 2072

A bill to promote affordable access to evidence-based opioid treatments under the Medicare program and require coverage of medication assisted treatment for opioid use disorders, opioid overdose reversal medications, and recovery support services by health plans without cost-sharing requirements.
A bill to promote affordable access to evidence-based opioid treatments under the Medicare program and require coverage of medication assisted treatment for opioid use disorders, opioid overdose reversal medications, and recovery support services by health plans without cost-sharing requirements.

Comments